Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • New Healthcare Industry Survey Reveals Majority of Healthcare Organizations Unprepared for ONC Cures Act Final Rule

    Apr 6, 2021, 15:46 PM by
    Full story
  • LabVantage Emphasizes Cybersecurity with Version 8.6 of Its LIMS Platform

    Apr 6, 2021, 15:46 PM by
    LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the 8.6 edition of its flagship LIMS has been designed and tested to optimum cybersecurity standards.
    Full story
  • LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS

    Apr 6, 2021, 15:46 PM by
    LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS. Adding validation support to a cloud-hosted, Software-as-a-Service (SaaS) LIMS increases confidence for organizations that function in regulated sectors, such as pharmaceuticals, biobanking, and clinical and molecular diagnostics.
    Full story
  • Drugs Repurposed To Tap Immune System In Fight Against Pathogens

    Apr 6, 2021, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease.
    Full story
  • MedAI Integrates Its Drug Research and Development Platform for the Pharmaceutical Industry

    Apr 5, 2021, 14:45 PM by
    Earlier this month, MedAI announces to have integrated its drug research and development platform for the pharmaceutical industry. The company is specialized in AI-assisted R&D and it now provides a wide range of solutions that covers nearly every stage of early drug development, including developing drug targets, biomarker discovery, chemical drug development, protein/antibody development, prediction of drug, crystal form, ADMET prediction, repurposing existing drugs, drug formulation development.
    Full story
  • Kiniciti Welcomes Two Cell and Gene Therapy Industry Leaders to its Advisory Board

    Apr 5, 2021, 14:45 PM by
    Kiniciti, a Welsh, Carson, Anderson & Stowe (“WCAS”) platform company that invests in non-therapeutic companies supporting Cell and Gene Therapy innovation, announced the formation of an Advisory Board and appointment of two inaugural members: Denis Bedoret, PhD, chief executive officer of Imcyse, and Andrew Knudten, chief operating officer of Jaguar Gene Therapy.
    Full story
  • Cresset expands its Board with the appointment of David Newble as Non-Executive Director

    Apr 5, 2021, 14:45 PM by
    Full story
  • Seven Bridges Launches the GRAF™ Population Solution — Population-Specific Tools and Services to Enhance Genetic Variation Discovery

    Apr 5, 2021, 14:45 PM by
    Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.
    Full story
  • Creative BioMart Biomarker Released Multiple Biomarker Detection Service

    Apr 5, 2021, 14:45 PM by
    Full story
  • Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support

    Apr 5, 2021, 14:45 PM by
    Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, announces Qlucore Omics Explorer (QOE) version 3.7, an extensive upgrade adding features in many different areas to strengthen visual analysis support even further.
    Full story
  • Formulationbio Newly Launches Disintegrant Excipients for Pharmaceutical Preparation

    Apr 5, 2021, 14:45 PM by
    Full story
  • Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company

    Apr 5, 2021, 14:43 PM by
    Full story
  • Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

    Apr 5, 2021, 14:43 PM by
    Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times.
    Full story
  • Baltimore Aircoil Company Highlights ENDURADRIVE® Fan System for Ideal Cooling in Mission-Critical Environments

    Apr 5, 2021, 14:43 PM by
    ENDURADRIVE® Fan System provides peace of mind and unmatched reliability, thanks to its advanced design
    Full story
  • Matexcel Offers a Comprehensive List of Graphene Products

    Apr 5, 2021, 14:43 PM by
    Full story
  • Tech and IoMT R&D Firm Commit Expands to North America Under Leadership of CRO and Managing Director, Max Nirenberg

    Apr 5, 2021, 14:43 PM by
    Commit, the leading Israeli-based global tech and custom software solutions firm is expanding into North America.
    Full story
  • Creative Biostructure Provides Various Vaccine Development Services for Coronavirus

    Apr 5, 2021, 14:43 PM by
    Full story
  • CD BioSciences is Ready to Provide Clinical Data Management Service

    Apr 5, 2021, 14:43 PM by
    CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.
    Full story
  • THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution

    Apr 5, 2021, 14:43 PM by
    THREAD and Lokavant partner
    Full story
  • Profacgen Provides Immunogenicity Testing Services to Help with Drug Discovery and Development

    Apr 5, 2021, 14:43 PM by
    Full story
  • «
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176 (current)
  • 177
  • 178
  • 179
  • 180
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy